Department of Chemical Pathology
The Chinese University of Hong Kong
Prince of Wales Hospital
Christopher Lam is Chairman and Chief of Service of the Department of Chemical Pathology, Director of the Clinical Immunology Unit, and Assistant Dean of Medicine (Research) at the 1,400-bed Prince of Wales Hospital, the Chinese University of Hong Kong, Hong Kong.
He has been President of the Asian and Pacific Federation of Clinical Biochemistry (APFCB, 2000-2004), and Executive Board member of IFCC (1999-2005). His honorary appointments and travelling lectureships include (1) Visiting Professor of Clinical Biochemistry for the People's Liberation Army General Hospital and Postgraduate Medical School, Beijing, China (since 2000), (2) Visiting Professor in Laboratory Medicine at the Chongqing Medical University, Chongqing, China (since 2000), (3) Roman Travelling Lecturer of the Australasian Association of Clinical Biochemists (AACB, 2002), (4) APFCB Travelling Lecturer (2005-2006), and (5) IFCC Visiting Lecturer to Croatia, Hungary and the Czech Republic (2008).
Professor Lam served as the Asian-Pacific Editor of the European journal Clinical Chemistry & Laboratory Medicine from 2006 to 2007, and has been an advisor of the Clinical Laboratory Science Institute (CLSI), USA (since 2005). He was elected Honorary Fellow of the Royal College of Pathologists, UK in 2006, awarded the APFCBDistinguished Service Medal in 2007, and conferred the IFCC Distinguished Award for Laboratory Medicine and Patient Care in 2008.
At work in Hong Kong Professor Lam fulfils a tripartite responsibility in teaching medical students, directing ahospital laboratory service, and participating in research.
He has published over 380 peer-reviewed papers in allergy and clinical immunology, lipidology, nephrology, endocrinology, and other aspects of chemical pathology including the laboratory medicine of emerging infectious diseases. Over recent years, his research interest has focused on aberrations of cytokines and chemokines and intracellular signalling in chronic diseases and acute infections, and the application of such new knowledge of immunopathology in clinical medicine and therapeutics.